Inflammation and atrophy precede prostatic neoplasia in a PhIP-induced rat model.

2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP) has been implicated as a major mutagenic heterocyclic amine in the human diet and is carcinogenic in the rat prostate. To validate PhIP-induced rat prostatic neoplasia as a model of human prostate cancer progression, we sought to study the earliest histologic and morphologic changes in the prostate and to follow progressive changes over time. We fed sixty-seven 5-week-old male Fischer F344 rats with PhIP (400 ppm) or control diets for 20 weeks, and then sacrificed animals for histomorphologic examination at the ages of 25, 45, and 65 weeks. Animals treated with PhIP showed significantly more inflammation (P = .002, > .001, and .016 for 25, 45, and 65 weeks, respectively) and atrophy (P = .003, > .001, and .006 for 25, 45, and 65 weeks, respectively) in their prostate glands relative to controls. Prostatic intraepithelial neoplasia (PIN) occurred only in PhIP-treated rats. PIN lesions arose in areas of glandular atrophy, most often in the ventral prostate. Atypical cells in areas of atrophy show loss of glutathione S-transferase pi immunostaining preceding the development of PIN. None of the animals in this study developed invasive carcinomas, differing from those in previous reports. Overall, these findings suggest that the pathogenesis of prostatic neoplasia in the PhIP-treated rat prostate proceeds from inflammation to postinflammatory proliferative atrophy to PIN.

[1]  Ulrike Peters,et al.  A prospective study of meat and meat mutagens and prostate cancer risk. , 2005, Cancer research.

[2]  Joachim Diebold,et al.  Functional epigenomics identifies genes frequently silenced in prostate cancer. , 2005, Cancer research.

[3]  P. Gumerlock,et al.  Abnormalities of apoptotic and cell cycle regulatory proteins in distinct histopathologic components of benign prostatic hyperplasia , 2004, Prostate Cancer and Prostatic Diseases.

[4]  Simak Ali,et al.  The cooked food derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine is a potent oestrogen: a mechanistic basis for its tissue-specific carcinogenicity. , 2004, Carcinogenesis.

[5]  M. Rubin,et al.  Prostate Pathology of Genetically Engineered Mice: Definitions and Classification. The Consensus Report from the Bar Harbor Meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee , 2004, Cancer Research.

[6]  Satoru Takahashi,et al.  High susceptibility of the ACI and spontaneously hypertensive rat (SHR) strains to 2‐amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine (PhIP) prostate carcinogenesis , 2003, Cancer science.

[7]  A. Clifford,et al.  Effect of Dietary Constituents With Chemopreventive Potential on Adduct Formation of a Low Dose of the Heterocyclic Amines PhIP and IQ and Phase II Hepatic Enzymes , 2003, Nutrition and cancer.

[8]  R. Roberts,et al.  Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma. , 2003, Cancer research.

[9]  N. Gooderham,et al.  Molecular and genetic toxicology of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). , 2002, Mutation research.

[10]  B. Pittman,et al.  On the occurrence of Leydig cell tumors in the F344 rat. , 2002, Cancer letters.

[11]  Jose J. Galvez,et al.  Prostatic intraepithelial neoplasia in genetically engineered mice. , 2002, The American journal of pathology.

[12]  K. Bogen,et al.  U.S. dietary exposures to heterocyclic amines* , 2001, Journal of Exposure Analysis and Environmental Epidemiology.

[13]  T. DeWeese,et al.  The molecular pathogenesis of prostate cancer: Implications for prostate cancer prevention. , 2001, Urology.

[14]  K. Imaida,et al.  Lack of chemopreventive effects of lycopene and curcumin on experimental rat prostate carcinogenesis. , 2001, Carcinogenesis.

[15]  G. Haas,et al.  Carcinogenicity of the N-hydroxy derivative of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, 2-amino-3, 8-dimethyl-imidazo[4,5-f]quinoxaline and 3, 2'-dimethyl-4-aminobiphenyl in the rat. , 2000, Cancer letters.

[16]  G. R. Stuart,et al.  Prostate mutations in rats induced by the suspected human carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. , 2000, Cancer research.

[17]  H. Schut,et al.  Tea as a Potential Chemopreventive Agent in PhIP Carcinogenesis: Effects of Green Tea and Black Tea on PhIP-DNA Adduct Formation in Female F-344 Rats , 2000, Nutrition and cancer.

[18]  J. Epstein,et al.  Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. , 1999, The American journal of pathology.

[19]  T. Shirai,et al.  Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) in the rat prostate and induction of invasive carcinomas by subsequent treatment with testosterone propionate. , 1999, Cancer letters.

[20]  N Ito,et al.  The prostate: a target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) derived from cooked foods. , 1997, Cancer research.

[21]  W. A. Gardner,et al.  Hypothesis: the prenatal origins of prostate cancer. , 1995, Human pathology.

[22]  T. P. Cameron,et al.  Histogenesis and morphology of naturally occurring prostatic carcinoma in the ACI/segHapBR rat. , 1980, Laboratory investigation; a journal of technical methods and pathology.

[23]  A. Berenguer Sánchez,et al.  [Diet and prostate cancer]. , 2003, Actas urologicas espanolas.

[24]  W. Isaacs,et al.  Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1. , 2001, Cancer research.

[25]  S. Schwartz,et al.  Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants. , 1999, The Journal of urology.

[26]  Smith Cj,et al.  Inflammation-proliferation: possible relationships in the prostate. , 1987 .

[27]  W. A. Gardner,et al.  Atrophy and proliferation in the young adult prostate. , 1987, The Journal of urology.

[28]  W. A. Gardner,et al.  Inflammation-proliferation: possible relationships in the prostate. , 1987, Progress in clinical and biological research.

[29]  J. Ward,et al.  Prostatic hyperplasia and neoplasia in aging F344 rats , 1981, The Prostate.